The significance of bariatric surgery in Egyptian patients with metabolic syndrome: a multicenter study

Faculty Medicine Year: 2020
Type of Publication: ZU Hosted Pages:
Authors:
Journal: Egyptian journal of internal medicine Wolter Kluwer - MedKnow Volume:
Keywords : , significance , bariatric surgery , Egyptian patients with metabolic    
Abstract:
Background Obesity and metabolic syndrome (MS) are global health concerns, with high rates of cardiovascular morbidity and mortality. The current guidelines recommend lifestyle modifications as the best initial treatment for obesity and MS. However, lifestyle interventions have modest effects and high 1-year failure rates. Bariatric surgery offers more weight loss with sustained effect in the long term. Aim The aim was to assess the effect of bariatric surgery on MS and all its components and to detect the probable risk factors for persistent MS after bariatric surgery in Egyptian patients. Patients and methods This prospective multicenter study included 250 obese patients who underwent bariatric surgery and completed 1 year of postoperative follow-up. The patients were evaluated preoperatively and at 1, 6, and 12 months postoperatively for presence of MS and its components according to criteria of the third report of National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP III). Results and discussion After 1 year of follow-up, the percentages of patients who had MS, obesity, type 2 diabetes mellitus, hypertension, hypertriglyceridemia, and low high-density lipoprotein-cholesterol were significantly decreased from 92, 100, 84, 50, 74, and 50% to 17, 2, 8, 17, 42, and 25%, respectively. Smoking, family history of obesity, and less percentage of excess weight loss were the most important risk factors for persistence of MS after bariatric surgery
   
     
 
       

Author Related Publications

  • Mohammed Ahmed Ali Bassiouni, "Sofosbuvir and daclatasvir plus ribavirin treatment improve liver function parameters and clinical outcomes in Egyptian chronic hepatitis C patients", Wolters Kluwer Health, Inc., 2017 More
  • Mohammed Ahmed Ali Bassiouni, "Lipocalin-2: A novel diagnostic marker for hepatocellular carcinoma", IOS press, 2020 More
  • Mohammed Ahmed Ali Bassiouni, "Management of HCV‑related decompensated cirrhosis with direct‑acting antiviral agents: who should be treated?", Springer, 2019 More
  • Mohammed Ahmed Ali Bassiouni, "Prevalence and Risk Factors of Minimal Hepatic Encephalopathy in Patients with Compensated Liver Cirrhosis", Ain Shams University, 2020 More
  • Mohammed Ahmed Ali Bassiouni, "Clinical Outcomes of Upper Gastrointestinal Bleeding in Egyptian Patients with Decompensated Liver Cirrhosis, Does the Bleeding Source Matter?", Ain Shams University, 2020 More

Department Related Publications

  • Ahmed Adel Hassan Muhamad, "اكتشاف ظهور ال69 باستخدام جهاز تدفق الخلايا لا يعتبر دلالة على الاستجابة التكاثرية التى تحدثها خلايا المعطى لخلايا الملتقى ", لايوجد, 1900 More
  • Usama Mohamed Ahmed Hassanein, "الارتداد المصري بالمرئ المصحوب والغير مصحوب باعراض مرئية وعلاقتة بالاعراض الصدرية في مرض الربو الشعبي", لايوجد, 1900 More
  • Ehab Mohamed Ahmed Salm, "دراسة الخلل الوظيفى للجدار المبطن للاوعية الدموية في ابناء مرض السكري من النوع الثاني بطريقة غير تداخلية", لايوجد, 1900 More
  • Hamed Abdelaziz Deraz, "اكتشاف الاجسام المضادة للكابيلاريا هيا تيكا فى مرض الكبد فى محافظة الشرقية ", لايوجد, 1900 More
  • Helmy Mohamed Youssef Elgendy, "البلازما د- دايمر انتجين كمتبى لنزيف الجهاز الهضمى العلوى ونتائجة العكسية", لايوجد, 1900 More
Tweet